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miRNA sequences. Inhibition of NF-κB and p38-MAPK activation with spe-
ciﬁc inhibitors down-regulated the expression of COX-2 but up-regulated
the expression of miR-101_3, miR-199a* in human OA chondrocytes sug-
gesting negative regulation of miR-101_3, miR-199a* by the activation of
these pathways.
Conclusions: Our data implicate miR-199a* in the post transcriptional
regulation of COX-2 expression in human OA chondrocytes. These results
also identify miR-199a* as a novel therapeutic target for the treatment of
OA.
185
ROLE OF C-TYPE NATRIURETIC PEPTIDE (CNP) IN OSTEOGENESIS AND
TREATMENT OF OSTEOPOROSIS
H. Bukulmez1,2 , T. Haqqi2, F. Khan1, J.F. Welter1, S. Murakami1
1Case Western Reserve Univ., Cleveland, OH; 2MetroHlth.Med. Ctr., Cleveland,
OH
Purpose: The recently described C-type natriuretic peptide (CNP) is critical
for normal longitudinal growth in humans and plays a central role in
osteoblast regulation in bone formation and regeneration. The purpose of
this study was to determine whether CNP has therapeutic potential in
osteoporosis or osteopenia secondary to inﬂammatory arthritis. Our goal
was to test whether CNP overproduction can reverse the osteoporosis that
develops in mouse disease models due to a lack of proper numbers and
function of osteoblasts to balance the resorptive effect of osteoclasts.
Methods: CNPCOL2A1TG mice have been generated by cloning human CNP
cDNA into a construct that contained the mouse collagen type II (COL2A1)
promoter and enhancer (GenBank #m65161). We initially assessed the
bone phenotype of mice that over-express CNP in chondrocytes in vivo.
We then made primary chondrocyte and osteoblast cultures from mouse
rib cage cartilage and calvarial osteoblasts. RNA and protein collected were
used to measure osteoblastic activity. We induced osteoporosis/osteopenia
by inducing chronic inﬂammatory arthritis in mice that over expressed CNP
compared to wild type in vivo.
Results: Phenotypic characteristics of the CNP over-expressing mice be-
came evident at 3-4 weeks of age. There was excessive elongation and
noticeable widening of the distal ends of long bones. Increased bone tra-
beculation in both primary and secondary ossiﬁcation centers was obvious
in histology, at 8-9 weeks of age in CNPCOL2A1TG mice. Micro-CT analysis
of age- and sex-matched littermates (4 female, 7 male), both wild type
and CNPCOL2A1TG, at various ages were analyzed. CNPCOL2A1TG mice showed
higher bone mineral density (BMD) and content (BMC) in the subchondral
bone in proximal tibia (Table 1). Trabeculation in the subchondral bone and
under the growth plate in CNPCOL2A1TG mice was also increased. CNPCOL2A1TG
mouse serum showed signiﬁcantly higher osteocalcin levels compared to
wild type from 8-13 weeks (p<0.005).
Table 1. Spine m-CT
Avg TbTh (μm) Trabecular BMC (mg) Cortical BMC (mg)
8 wk f WT (n=2) 50.57 (±1.02) 4.80 (±0.18) 7.65 (±0.2)
8 wk f CNPCOL2A1TG (n=2) 52.44 (±0.12) 6.95 (±0.03) 9.90 (±0.8)
14 wk f WT (n=4) 77.70 (±1.2) 3.51 (± 0.80) 8.16 (±0.9)
14 wk f CNPCOL2A1TG (n=2) 91.40 (±2.4) 7.43 (±1.20) 13.57 (±1.3)
Quantitative RT-PCR analysis showed that, in both primary chondrocytes
and osteoblast cultures, collagen II, X, I, OPG, osteocalcin were expressed
at signiﬁcantly higher levels in the CNPCOL2A1TG mouse chondrocytes or
when calvarial osteoblasts were treated with exogenous CNP (10ng/ml,
> 3wk). However, RANKL mRNA was found to be decreased 2.5 fold
in CNPCOL2A1TG mouse chondrocytes and osteoblasts. When we induced
systemic arthritis using the K/BxN TCR serum model in mice (n=32) that
were either CNPCOL2A1TG or wild type, the CNPCOL2A1TG mice did not develop
Figure 1. Osteocalcin (ng/ml).
endochondral delay or periarticular bone loss/osteoporosis even after 4
weeks of systemic arthritis compared to wild type. Serum osteocalcin lev-
els, measured after the K/BxN TCR arthritis developed, showed decreased
levels at 2.5, 3.5 and 5 months-of-age (Fig. 1). Interestingly, CNPCOL2A1TG
mice continued to maintain high osteocalcin levels even after arthritis
developed. Micro-CT analysis suggested that CNPCOL2A1TG mice that devel-
oped arthritis were resistant to both trabecular and cortical bone mineral
density loss due to inﬂammatory changes in the joint. Trabecular thickness,
inter-trabecular space and the connectivity of the trabecular structure were
not different in wild type (WT) and K/BxN TCR mice.
Conclusions: Our observations from in vivo and in vitro experiments sug-
gest a clear effect of CNP signaling in osteogenesis and suggest a role in
osteoporosis treatment during systemic arthritis.
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Purpose: Studies from our lab have previously demonstrated that there
is rapid activation of a number of intracellular signalling pathways upon
explantation of porcine articular cartilage including the three mitogen acti-
vated protein kinases (MAPKs); c-jun N terminal kinase (JNK), p38, and the
extracellularly regulated kinase (ERK) (Gruber, 2004), as well as activation
of NFkB and PI3 kinase (unpublished). Re-cutting cartilage that has been
rested in serum free medium for 48h results in activation of the ERK
pathway only, and is due to release of FGF2 from the pericellular matrix.
In order to determine the relative contribution of FGF2 to the explantation
response, we set up signalling assays and studied gene induction in injured
murine hip cartilage from wild type (WT) and FGF2 null mice.
Methods: Murine cartilage from 4-6 week old WT or FGF2 null mice was
explanted from the intact hip by blunt dissection, and was either lysed
immediately, or was cultured in serum free medium for up to 24h. Some
explanted cartilage was rested in serum free medium (48h), then was
re-cut. Protein was extracted from the hips (3-5 for signalling experiments)
for phospho-western blotting for pERK, pJNK, pP38 and pIkappaB. Equal
protein loading was conﬁrmed by re-blotting for total ERK, IkB or tubulin.
Gene analysis was performed on 5-8 hip explants (either explanted, re-cut
or stimulated with FGF2). Messenger RNA was extracted using Trizol and
puriﬁed. Quantitative RT-PCR for 48 pre-selected candidate genes using
Taqman microﬂuidic cards was performed.
Results: Cartilage explantation led to early activation of MAPK pathways as
well as causing phosphorylation of IkB, indicative of activation of NFkB. A
very weak activation of inﬂammatory pathways was apparent when rested
cartilage was re-cut. When FGF2 null cartilage was explanted there was
an approximate 50% reduction in MAPK activation. A number of genes (se-
lected from an unpublished murine OA microarray study) were regulated
in the chondrocytes following explantation. These are listed in Table 1.
Some of these genes were also regulated when the tissue was re-cut (rather
than explanted), and those same genes were shown to be strongly induced
by stimulation with recombinant FGF2. CCL2, arginase 1, IL-1α, CCL7 and
Table 1
Legend: Arg1 - arginase 1; CCL - CC chemokine ligand; HAS1 - hyaluronan synthase 1;
CD14 - cluster differentiation 14; TNFRSF12a - TNF Receptor superfamily member 12a;
TSG6 - TNF stimulated gene 6; TIMP1 - tissue inhibitor of metalloproteinase 1; Ptges -
prostaglandin E synthase.
